1. Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
- Author
-
Raoul Orvieto, Christos A. Venetis, Human M. Fatemi, Thomas D’Hooghe, Robert Fischer, Yulia Koloda, Marcos Horton, Michael Grynberg, Salvatore Longobardi, Sandro C. Esteves, Sesh K. Sunkara, Yuan Li, and Carlo Alviggi
- Subjects
assisted reproductive technology (ART) ,optimisation ,ovarian stimulation ,gonadotropins ,luteal phase support ,oocyte maturation ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
BackgroundA Delphi consensus was conducted to evaluate global expert opinions on key aspects of assisted reproductive technology (ART) treatment.MethodsTen experts plus the Scientific Coordinator discussed and amended statements plus supporting references proposed by the Scientific Coordinator. The statements were distributed via an online survey to 35 experts, who voted on their level of agreement or disagreement with each statement. Consensus was reached if the proportion of participants agreeing or disagreeing with a statement was >66%.ResultsEighteen statements were developed. All statements reached consensus and the most relevant are summarised here. (1) Follicular development and stimulation with gonadotropins (n = 9 statements): Recombinant human follicle stimulating hormone (r-hFSH) alone is sufficient for follicular development in normogonadotropic patients aged
- Published
- 2021
- Full Text
- View/download PDF